Ben And Catherine Ivy Foundation | Foundation Profile
GrantBay analyzes IRS Form 990-PF data to help grant seekers find fit funders like Ben And Catherine Ivy Foundation. Data shown is extracted from Form 990-PF filings.
EIN: 27-3322123
Foundation Overview
Based in Scottsdale, AZ, Ben And Catherine Ivy Foundation has awarded 192 grants totaling $110,710,056 to organizations in Arizona, Texas and 15 other states across the US. Individual grants range from $100 to $5,970,000, with a median award of $268,998.
Latest Tax Year
2023
Total Giving (all years)
$110,710,056
Total Assets
$333,226,223
Median Grant (all grants)
$268,998
Latest Form 990-PF Snapshot
Total Grants
56
Median Grant
$299,296
% Median Grant Growth
+20%
(vs previous year)
Data extracted from IRS Form 990-PF filings. Last filing year:
February 2026
Foundation Intelligence
Advanced analytics and strategic insights to help nonprofit organizations assess grant opportunities and optimize their application strategies
New Applicant Friendliness
Balanced Approach: 43%
24 of 56 recipients (43%) were new grantees. Foundation maintains loyal partnerships while remaining open to qualified new applicants with strong proposals.
Geographic Focus
Arizona
Grants are geographically diversified with 34% in Arizona and funding distributed across 17 total locations. This foundation values broad geographic impact and diverse community partnerships. Within Arizona, funding concentrates in Phoenix (88%), Scottsdale (6%), Tempe (5%).
Funding Trajectory
+4%
Stable funding levels with 4% change over 3 years indicate consistent grant-making capacity and predictable philanthropic resources. This stability suggests reliable ongoing funding opportunities.
Program Areas
Healthcare + 3 others
Diversified giving across multiple program areas with primary emphasis on healthcare (62%). This broad approach suggests openness to various causes and innovative cross-sector solutions.
Where is The Money Going?
Loading geographic data...
Loading chart...
Loading chart...
Loading chart...
Grants & Funding
Analyzing past grantees provides valuable insights into Ben And Catherine Ivy Foundation's funding preferences, organizational priorities, and grant making patterns. This historical data helps potential applicants understand the foundation's strategic focus and identify successful funding approaches.
| Name | Amount | Location | Purpose | Year |
|---|---|---|---|---|
| Uc San Diego | $300,000 | La Jolla, CA, US | Small Molecule Regulation Of Rest Protein Levels Provides An Ideal Platform For Developing A New Therapeutic For The Treatment Of Glioblastoma Multiforme. Payment 2 Of 2. | 2023 |
| University Of Tx Md Anderson Cancer | $250,000 | Houston, TX, US | Develop Safe And Potent Drugs That Can Turn The Tumor Immune Microenvironment From Suppressive To Permissive, Thereby Helping The Immune System To Recognize And Kill Glioblastoma. Payment 2 Of 2. | 2023 |
| Swedish Medical Center | $300,500 | Seattle, WA, US | Assess Combinations Of Small Molecules And Immunotherapies For Killing Glioblastoma Tumor Cells In A Personalized Ex Vivo Ecosystem With Intact Tumor Microenvironment Using Multiplex Immunochemistry And Spatial Mapping Of Cell Types. | 2023 |
| Society Of St Vincent De Paul | $380,000 | Phoenix, AZ, US | Center For Family Wellness Established To Focus On The Prevention And Management Of Chronic Diseases Through Nutrition, Physical Activity And Overall Wellness. Its Culturally Grounded Bilingual Education Programs Encourage The Whole Family To Participate. | 2023 |
| Arcs Foundation | $8,800 | Artesia, CA, US | Advance Science And Technology In The United States By Providing Awards To Academically Outstanding Us Citizens Studying To Complete Degrees In Science, Engineering And Medical Research. | 2023 |
| University Of Michigan | $250,000 | Ann Arbor, MI, US | Develop Quantitative Methods To Assess Methionnine Metabolism And Test The Efficacy Of Methionne-directed Therapeutics In Mouse Models And Patients With Glioblastoma. Pmt 1 Of 2. | 2023 |
| City Of Hope Medical Center | $300,000 | Duarte, CA, US | Phase I Clinical Trial To Evaluate The Feasibility, Safety, And Clinical Efficacy Of Tgf-resistant Ilira2-car T Cells For Treatment Of Recurrent Glioblastoma. Pmt #1 Of 2. | 2023 |
| Mayo Clinic | $300,000 | Jacksonville, FL, US | Identify The Oncogenic Signaling Dependencies That Characterize Each Of The Cellular Subpopulations That Comprise A Glioblastoma Tumor, And From This Information Construct A Non-toxic Combination Of Kinase Inhibitors To Effectively Treat This Disease. Payment 2 Of 2. | 2023 |
| Maricopa Community Colleges Foundat | $130,500 | Tempe, AZ, US | The Foundation Actively Seeks Contributions From A Variety Of Private Sources Including Individuals, Corporations, And Foundations And Believes That Everyone Has The Opportunity To Improve Their Lives Through Education. Mcccdf Works To Fulfill This Vision With Its Mission To Boldly Impact The Community Through Innovative And Strategic Partnerships For The Growth And Benefit Of The Maricopa Community Colleges, Its Students, Faculty, And Staff. | 2023 |
| Translational Genomics Research Tge | $100,218 | Phoenix, AZ, US | Neurological Sciences Internship Program At Tgen Designed To Give High School And Undergraduate Students Intensive, Hands-on Research Experience Working Alongside A Mentor-scientist To Learn About Translational Research While Investigating Questions Within The Neurological Sciences. | 2023 |
| University Of Tx Md Anderson Cancer | $300,000 | Houston, TX, US | Project Seeks To Preclinically Optimize Novel Therapeutic Approaches For Atrx-deficient Malignant Gliomas Targeting G-quadruplex Dna Secondary Structure. Payment 2 Of 2. | 2023 |
| St Joseph's Foundation | $135,000 | Phoenix, AZ, US | Supports Patient Care, Medical Education, Research And Community Outreach At St. Joseph Hospital. | 2023 |
| St Joseph's Foundation | $5,970,000 | Phoenix, AZ, US | Ivy Brain Tumor Center At Barrow Neurological Institute Capital Expenditures. | 2023 |
| Neuro Trials Llc | $3,800,935 | Phoenix, AZ, US | Multiple Awards:1) Development Of Triple-drug Cocktails To Induce Glioblastoma.2) Ucsf Preclinical Core For Drug Development At The Ivy Brain Tumor Center.3)10 Year Ibtc Grant4) Matching Funds National Gbm Day | 2023 |
| Damon Runyon Cancer Research Fdn | $130,000 | New York, NY, US | Investigation Of A Biomarker Phase 2 Study To Evaluate Targeted Therapy Harboring Specific Genetic Alterations. 4th And Final Pmt. | 2023 |
| Memorial Sloan Kettering Cancer Cen | $300,000 | New York, NY, US | Discover And Describe Dormant Tumor Cells Called Cancer Stem Cells That Reside Within Adult Glioma And Are Resistant To Current Therapies. Payment 2 Of 2. | 2023 |
| Columbia University Irving Medical | $250,000 | New York, NY, US | Targeting The Glioblastoma Master Regulator Cebp A Pharmacokinetics And Pharmacodynamics Surgical Study Of St101. Payment 2 Of 2. | 2023 |
| Mayo Clinic College Of Medicine | $300,000 | Rochester, MN, US | Evaluate Candidate Glioma Csf Proteomic Signatures To Help Understand And Monitor Glioma Evolution In Living Patients During Standard Of Care And Experimental Immunotherapy. Payment 2 Of 2. | 2023 |
| Indiana University Foundation | $298,592 | Bloomington, IN, US | Determine The Structural Basis And Molecular Mechanism Of Action Of Sum01 Degraders In Treatment Of Glioblastoma, Alone And In Combination With Current Standard Chemo And Radiotherapy. | 2023 |
| Children's Hospital Of Philadelphia | $300,000 | Philadelphia, PA, US | Engineering A Multi-antigen Targeting Car T Therapy With Confined Activites Within The Tumor Microenvironment To Treat Antigenically Heterogenous Adult Glioblastoma. | 2023 |
| University Of Virginia | $300,000 | Charlottesville, VA, US | Develop Small Molecule Inhibitors Of A Newly Identified Oncogene In Glioblastoma. Pmt 1 Of 2. | 2023 |
| University Of Virginia | $300,000 | Charlottesville, VA, US | Develop And Test New Therapies For Glioblastoma Using Micornas. Pmt 1 Of 2. | 2023 |
| University Of Virginia | $300,000 | Charlottesville, VA, US | Develop And Deploy Strategies For Leveraging Mri-guided Focused Ultrasound Therapy To Potentiate Car-t Cell Therapy Against Adult High-grade Gliomas. Pmt 1 Of 2. | 2023 |
| Vanguard Charitable | $25,000 | Warwick, RI, US | Increase Philanthropy And Maximize Its Impact Over Time. | 2023 |
| Az Bio | $5,000 | Phoenix, AZ, US | Provides Ethics Resources With Particular Attention To Those Affecting Arizonans. 2023 Grant. | 2023 |
| Leukemia Lymphoma Society | $250 | Phoenix, AZ, US | Supports The Development Of New Treatments For Cancer And Breaking Down The Barriers To Care That Patients Often Encounter. | 2023 |
| Tpworg | $3,000 | San Francisco, CA, US | Providing Philanthropy Tools And Information To Individuals And Families Whose Needs Were Not Being Sufficiently Met By Financial Advisors And Other Existing Resources. | 2023 |
| Common Spirit Health Foundation | $5,000 | San Francisco, CA, US | Focused On Making Health Equity A Reality Across The Country Through Pioneering Programs That Ensure Greater Access To Care, Create Community Partnerships And Participation And Advocate For Those Who Are Vulnerable. | 2023 |
| Uc San Diego | $300,000 | La Jolla, CA, US | Small Molecule Regulation Of Rest Protein Levels Provides An Ideal Platform For Developing A New Therapeutic For The Treatment Of Glioblastoma Multiforme. Payment 2 Of 2. | 2023 |
| University Of Tx Md Anderson Cancer | $250,000 | Houston, TX, US | Develop Safe And Potent Drugs That Can Turn The Tumor Immune Microenvironment From Suppressive To Permissive, Thereby Helping The Immune System To Recognize And Kill Glioblastoma. Payment 2 Of 2. | 2023 |
| Swedish Medical Center | $300,500 | Seattle, WA, US | Assess Combinations Of Small Molecules And Immunotherapies For Killing Glioblastoma Tumor Cells In A Personalized Ex Vivo Ecosystem With Intact Tumor Microenvironment Using Multiplex Immunochemistry And Spatial Mapping Of Cell Types. | 2023 |
| Society Of St Vincent De Paul | $380,000 | Phoenix, AZ, US | Center For Family Wellness Established To Focus On The Prevention And Management Of Chronic Diseases Through Nutrition, Physical Activity And Overall Wellness. Its Culturally Grounded Bilingual Education Programs Encourage The Whole Family To Participate. | 2023 |
| Arcs Foundation | $8,800 | Artesia, CA, US | Advance Science And Technology In The United States By Providing Awards To Academically Outstanding Us Citizens Studying To Complete Degrees In Science, Engineering And Medical Research. | 2023 |
| University Of Michigan | $250,000 | Ann Arbor, MI, US | Develop Quantitative Methods To Assess Methionnine Metabolism And Test The Efficacy Of Methionne-directed Therapeutics In Mouse Models And Patients With Glioblastoma. Pmt 1 Of 2. | 2023 |
| City Of Hope Medical Center | $300,000 | Duarte, CA, US | Phase I Clinical Trial To Evaluate The Feasibility, Safety, And Clinical Efficacy Of Tgf-resistant Ilira2-car T Cells For Treatment Of Recurrent Glioblastoma. Pmt #1 Of 2. | 2023 |
| Mayo Clinic | $300,000 | Jacksonville, FL, US | Identify The Oncogenic Signaling Dependencies That Characterize Each Of The Cellular Subpopulations That Comprise A Glioblastoma Tumor, And From This Information Construct A Non-toxic Combination Of Kinase Inhibitors To Effectively Treat This Disease. Payment 2 Of 2. | 2023 |
| Maricopa Community Colleges Foundat | $130,500 | Tempe, AZ, US | The Foundation Actively Seeks Contributions From A Variety Of Private Sources Including Individuals, Corporations, And Foundations And Believes That Everyone Has The Opportunity To Improve Their Lives Through Education. Mcccdf Works To Fulfill This Vision With Its Mission To Boldly Impact The Community Through Innovative And Strategic Partnerships For The Growth And Benefit Of The Maricopa Community Colleges, Its Students, Faculty, And Staff. | 2023 |
| Translational Genomics Research Tge | $100,218 | Phoenix, AZ, US | Neurological Sciences Internship Program At Tgen Designed To Give High School And Undergraduate Students Intensive, Hands-on Research Experience Working Alongside A Mentor-scientist To Learn About Translational Research While Investigating Questions Within The Neurological Sciences. | 2023 |
| University Of Tx Md Anderson Cancer | $300,000 | Houston, TX, US | Project Seeks To Preclinically Optimize Novel Therapeutic Approaches For Atrx-deficient Malignant Gliomas Targeting G-quadruplex Dna Secondary Structure. Payment 2 Of 2. | 2023 |
| St Joseph's Foundation | $135,000 | Phoenix, AZ, US | Supports Patient Care, Medical Education, Research And Community Outreach At St. Joseph Hospital. | 2023 |
| St Joseph's Foundation | $5,970,000 | Phoenix, AZ, US | Ivy Brain Tumor Center At Barrow Neurological Institute Capital Expenditures. | 2023 |
| Neuro Trials Llc | $3,800,935 | Phoenix, AZ, US | Multiple Awards:1) Development Of Triple-drug Cocktails To Induce Glioblastoma.2) Ucsf Preclinical Core For Drug Development At The Ivy Brain Tumor Center.3)10 Year Ibtc Grant4) Matching Funds National Gbm Day | 2023 |
| Damon Runyon Cancer Research Fdn | $130,000 | New York, NY, US | Investigation Of A Biomarker Phase 2 Study To Evaluate Targeted Therapy Harboring Specific Genetic Alterations. 4th And Final Pmt. | 2023 |
| Memorial Sloan Kettering Cancer Cen | $300,000 | New York, NY, US | Discover And Describe Dormant Tumor Cells Called Cancer Stem Cells That Reside Within Adult Glioma And Are Resistant To Current Therapies. Payment 2 Of 2. | 2023 |
| Columbia University Irving Medical | $250,000 | New York, NY, US | Targeting The Glioblastoma Master Regulator Cebp A Pharmacokinetics And Pharmacodynamics Surgical Study Of St101. Payment 2 Of 2. | 2023 |
| Mayo Clinic College Of Medicine | $300,000 | Rochester, MN, US | Evaluate Candidate Glioma Csf Proteomic Signatures To Help Understand And Monitor Glioma Evolution In Living Patients During Standard Of Care And Experimental Immunotherapy. Payment 2 Of 2. | 2023 |
| Indiana University Foundation | $298,592 | Bloomington, IN, US | Determine The Structural Basis And Molecular Mechanism Of Action Of Sum01 Degraders In Treatment Of Glioblastoma, Alone And In Combination With Current Standard Chemo And Radiotherapy. | 2023 |
| Children's Hospital Of Philadelphia | $300,000 | Philadelphia, PA, US | Engineering A Multi-antigen Targeting Car T Therapy With Confined Activites Within The Tumor Microenvironment To Treat Antigenically Heterogenous Adult Glioblastoma. | 2023 |
| University Of Virginia | $300,000 | Charlottesville, VA, US | Develop Small Molecule Inhibitors Of A Newly Identified Oncogene In Glioblastoma. Pmt 1 Of 2. | 2023 |
| University Of Virginia | $300,000 | Charlottesville, VA, US | Develop And Test New Therapies For Glioblastoma Using Micornas. Pmt 1 Of 2. | 2023 |
| University Of Virginia | $300,000 | Charlottesville, VA, US | Develop And Deploy Strategies For Leveraging Mri-guided Focused Ultrasound Therapy To Potentiate Car-t Cell Therapy Against Adult High-grade Gliomas. Pmt 1 Of 2. | 2023 |
| Vanguard Charitable | $25,000 | Warwick, RI, US | Increase Philanthropy And Maximize Its Impact Over Time. | 2023 |
| Az Bio | $5,000 | Phoenix, AZ, US | Provides Ethics Resources With Particular Attention To Those Affecting Arizonans. 2023 Grant. | 2023 |
| Leukemia Lymphoma Society | $250 | Phoenix, AZ, US | Supports The Development Of New Treatments For Cancer And Breaking Down The Barriers To Care That Patients Often Encounter. | 2023 |
| Tpworg | $3,000 | San Francisco, CA, US | Providing Philanthropy Tools And Information To Individuals And Families Whose Needs Were Not Being Sufficiently Met By Financial Advisors And Other Existing Resources. | 2023 |
| Common Spirit Health Foundation | $5,000 | San Francisco, CA, US | Focused On Making Health Equity A Reality Across The Country Through Pioneering Programs That Ensure Greater Access To Care, Create Community Partnerships And Participation And Advocate For Those Who Are Vulnerable. | 2023 |
| Translational Genomics Research Tge | $78,293 | Phoenix, AZ, US | Neurological Sciences Internship Program At Tgen Designed To Give High School And Undergraduate Students Intensive, Hands-on Research Experience Working Alongside A Mentor-scientist To Learn About Translational Research While Investigating Questions Within Neurological Sciences. | 2022 |
| Ut Southwestern Medical Center | $210,430 | Dallas, TX, US | Preclinical Investigation Of Focus Ultrasound Guided Delivery To Facilitate A Lipoprotein-omega-3 Fatty Acid-based Biological Therapy In Glioblastoma. Payment 2 Of 2. | 2022 |
| Neuro Trials Llc | $5,000,000 | Phoenix, AZ, US | Ivy Brain Tumor Center Building Expansion Special Grant Amendment. | 2022 |
| Uc San Diego | $300,000 | La Jolla, CA, US | Small Molecule Regulation Of Rest Protein Levels Provides An Ideal Platform For Developing A New Therapeutic For The Treatment Of Glioblastoma Multiforme. Payment 1 Of 2. | 2022 |
| University Of Tx Md Anderson Cancer | $250,000 | Houston, TX, US | Develop Safe And Potent Drugs That Can Turn The Tumor Immune Microenvironment From Suppressive To Permissive, Thereby Helping The Immune System To Recognize And Kill Glioblastoma. Payment 1 Of 2. | 2022 |
| Swedish Medical Center | $300,000 | Seattle, WA, US | Assess Combinations Of Small Molecules And Immunotherapies For Killing Glioblastoma Tumor Cells In A Personalized Ex Vivo Ecosystem With Intact Tumor Microenvironment Using Multiplex Immunochemistry And Spatial Mapping Of Cell Types. Payment 1 Of 2. | 2022 |
| Mayo Clinic College Of Medicine | $208,347 | Rochester, MN, US | Immunostimulatory Bacterial Antigens Expressed In Oncolytic Viral Platforms Will Be Tested In Preclinical Models Of Glioblastoma To Overcome Immune Checkpoint Inhibitor Resistance. Payment 2 Of 2. | 2022 |
| Society Of St Vincent De Paul | $250,000 | Phoenix, AZ, US | Center For Family Wellness Established To Focus On The Prevention And Management Of Chronic Diseases Through Nutrition, Physical Activity And Overall Wellness. Its Culturally Grounded Bilingual Education Programs Encourage The Whole Family To Participate. Payment #3. | 2022 |
| Arcs Foundation | $8,800 | Artesia, CA, US | Advance Science And Technology In The United States By Providing Awards To Academically Outstanding Us Citizens Studying To Complete Degrees In Science, Engineering And Medical Research. | 2022 |
| University Of Michigan | $300,000 | Ann Arbor, MI, US | New Methods Will Be Developed To Measure The Activity Of Tumor Metabolic Pathways In Patients With Glioblastoma And To Determine Whether Drugs Designed To Block These Pathways Are Suitable. Payment 2 Of 2. | 2022 |
| Univ Of New Mexico Health Sciences | $300,000 | Albuquerque, NM, US | Identify Mechanisms Underlying Inflammatory Cell Contribution To The Emergence Of The Recurrent Tumor By Single-cell Analysis Of Residual Disease In Glioblastoma Patients. Payment 2 Of 2. | 2022 |
| Univ Of Miami Miller School Of Medi | $300,000 | Miami, FL, US | Using Patient Derived Orthotopic Xenograft Models And A Novel Immunocompetent Model Of Gbm, The Efficacy Of A Mtl-mmp Inhibitor In Combination With Radiation/tmz Will Be Tested To Determine Its Effects On The Immune Component Of The Tumor Microenvironment. Payment 2 Of 2. | 2022 |
| Mayo Clinic | $268,998 | Jacksonville, FL, US | Identify The Oncogenic Signaling Dependencies That Characterize Each Of The Cellular Subpopulations That Comprise A Glioblastoma Tumor, And From This Information Construct A Non-toxic Combination Of Kinase Inhibitors To Effectively Treat This Disease. Payment 1 Of 2. | 2022 |
| Notmykid | $1,000 | Scottsdale, AZ, US | Lifesaving Programs, Support, Resources, And Education To Empower Adn Educate Youth, Familes, And Communities With The Knowledge And Courage To Identify And Prevent Negative Youth Behavior. | 2022 |
| Neurotrials Llc | $450,000 | Phoenix, AZ, US | Cerebrospinal Fluid Analysis With T-gen. | 2022 |
| Neurotrials Llc | $5,470,000 | Phoenix, AZ, US | Prepayment Of 2023 Cerebrospinal Fluid Analysis. | 2022 |
| Neuro Trials Llc | $200,000 | Phoenix, AZ, US | Deposit For Ivy Brain Tumor Center Building Lobby. | 2022 |
| O'connor Institute | $500 | Phoenix, AZ, US | Advances Sandra Day O'connor's Distinguished Legacy And Lifetime Work To Advance Civics Education, Civic Engagement And Civil Discourse. | 2022 |
| Translational Genomics Research Tge | $-280,947 | Phoenix, AZ, US | Refund Of Unused Funds. | 2022 |
| Yale Cancer Center | $300,000 | New Haven, CT, US | Use Of A Novel Transformational Platform For Rapid Identification Of Targets And Treatments To Inhibit Growth And Invasion Of Glioblastoma Cells Based On Rapid Patient Sample Screening Using Novel Nano-engineering Techniques. Payment 2 Of 2. | 2022 |
| University Of Tx Md Anderson Cancer | $300,000 | Houston, TX, US | Project Seeks To Preclinically Optimize Novel Therapeutic Approaches For Atrx-deficient Malignant Gliomas Targeting G-quadruplex Dna Secondary Structure. Payment 1 Of 2. | 2022 |
| Barrow Neurological Fdn | $4,500 | Phoenix, AZ, US | Provides Philanthropic Support For Barrow Neurological Institute At St. Joseph's Hospital And Medical Center. Barrow Is An International Leader In The Treatment, Research, And Education Of Brain And Spinal Diseases, Conditions And Injuries. | 2022 |
| H Lee Moffitt Cancer Center | $300,000 | Rochester, MN, US | In Examining The Role Of Tumors Cells In Modulating Bone Marrow-derived Macrophages And Microglia, This Study Seeks To Tailor Novel Therapeutics For Targeting Of Tumor Associated Macrophages. Payment 2 Of 2. | 2022 |
| Virginia Tech | $250,000 | Roanoke, VA, US | To Inhibit Tumor Cell Invasion And Invasion, Targeted Therapeutics Will Be Coupled To Biomarker-based Imaging In Patient-specific Models Of Glioblastoma. Payment 2 Of 2. | 2022 |
| Vanderbilt University | $250,000 | Nashville, TN, US | Using Single-cell And Systems Biology Approaches In Glioblastoma, Cell Subtypes Will Be Mapped To Glioblastoma Tissues And Experimental Models, Enabling Identification And Preclinical Targeting Of Interactions Between Cancer Cells, Immune Cells, And Location Specific Resident Brain Cells. Payment 2 Of 2. | 2022 |
| Damon Runyon Cancer Research Fdn | $120,000 | New York, NY, US | Investigation Of A Biomarker Phase 2 Study To Evaluate Targeted Therapy Harboring Specific Genetic Alterations. Payment 3 | 2022 |
| Memorial Sloan Kettering Cancer Cen | $300,000 | New York, NY, US | Discover And Describe Dormant Tumor Cells Called Cancer Stem Cells That Reside Within Adult Glioma And Are Resistant To Current Therapies. Payment 1 Of 2. | 2022 |
| Columbia University Irving Medical | $250,000 | New York, NY, US | Targeting The Glioblastoma Master Regulator Cebp A Pharmacokinetics And Pharmacodynamics Surgical Study Of St101. Payment 1 Of 2. | 2022 |
| Mayo Clinic College Of Medicine | $300,000 | Rochester, MN, US | Evaluate Candidate Glioma Csf Proteomic Signatures To Help Understand And Monitor Glioma Evolution In Living Patients During Standard Of Care And Experimental Immunotherapy. Payment 1 Of 2. | 2022 |
| Amanda Hope Rainbow | $500 | Phoenix, AZ, US | Bringing Dignity And Comfort Into The Harsh World Of Childhood Cancer And Other Threatening Diseases. | 2022 |
| Lung Cancer Research Foundation | $150 | New York, NY, US | Improves Lung Cancer Outcomes By Funding Research For The Prevention, Diagnosis, Treatment And Cure Of Lung Cancer. | 2022 |
| Translational Genomics Research Tge | $78,293 | Phoenix, AZ, US | Neurological Sciences Internship Program At Tgen Designed To Give High School And Undergraduate Students Intensive, Hands-on Research Experience Working Alongside A Mentor-scientist To Learn About Translational Research While Investigating Questions Within Neurological Sciences. | 2022 |
| Ut Southwestern Medical Center | $210,430 | Dallas, TX, US | Preclinical Investigation Of Focus Ultrasound Guided Delivery To Facilitate A Lipoprotein-omega-3 Fatty Acid-based Biological Therapy In Glioblastoma. Payment 2 Of 2. | 2022 |
| Neuro Trials Llc | $5,000,000 | Phoenix, AZ, US | Ivy Brain Tumor Center Building Expansion Special Grant Amendment. | 2022 |
| Uc San Diego | $300,000 | La Jolla, CA, US | Small Molecule Regulation Of Rest Protein Levels Provides An Ideal Platform For Developing A New Therapeutic For The Treatment Of Glioblastoma Multiforme. Payment 1 Of 2. | 2022 |
| University Of Tx Md Anderson Cancer | $250,000 | Houston, TX, US | Develop Safe And Potent Drugs That Can Turn The Tumor Immune Microenvironment From Suppressive To Permissive, Thereby Helping The Immune System To Recognize And Kill Glioblastoma. Payment 1 Of 2. | 2022 |
| Swedish Medical Center | $300,000 | Seattle, WA, US | Assess Combinations Of Small Molecules And Immunotherapies For Killing Glioblastoma Tumor Cells In A Personalized Ex Vivo Ecosystem With Intact Tumor Microenvironment Using Multiplex Immunochemistry And Spatial Mapping Of Cell Types. Payment 1 Of 2. | 2022 |
| Mayo Clinic College Of Medicine | $208,347 | Rochester, MN, US | Immunostimulatory Bacterial Antigens Expressed In Oncolytic Viral Platforms Will Be Tested In Preclinical Models Of Glioblastoma To Overcome Immune Checkpoint Inhibitor Resistance. Payment 2 Of 2. | 2022 |
| Society Of St Vincent De Paul | $250,000 | Phoenix, AZ, US | Center For Family Wellness Established To Focus On The Prevention And Management Of Chronic Diseases Through Nutrition, Physical Activity And Overall Wellness. Its Culturally Grounded Bilingual Education Programs Encourage The Whole Family To Participate. Payment #3. | 2022 |
| Arcs Foundation | $8,800 | Artesia, CA, US | Advance Science And Technology In The United States By Providing Awards To Academically Outstanding Us Citizens Studying To Complete Degrees In Science, Engineering And Medical Research. | 2022 |
| University Of Michigan | $300,000 | Ann Arbor, MI, US | New Methods Will Be Developed To Measure The Activity Of Tumor Metabolic Pathways In Patients With Glioblastoma And To Determine Whether Drugs Designed To Block These Pathways Are Suitable. Payment 2 Of 2. | 2022 |
| Univ Of New Mexico Health Sciences | $300,000 | Albuquerque, NM, US | Identify Mechanisms Underlying Inflammatory Cell Contribution To The Emergence Of The Recurrent Tumor By Single-cell Analysis Of Residual Disease In Glioblastoma Patients. Payment 2 Of 2. | 2022 |
| Univ Of Miami Miller School Of Medi | $300,000 | Miami, FL, US | Using Patient Derived Orthotopic Xenograft Models And A Novel Immunocompetent Model Of Gbm, The Efficacy Of A Mtl-mmp Inhibitor In Combination With Radiation/tmz Will Be Tested To Determine Its Effects On The Immune Component Of The Tumor Microenvironment. Payment 2 Of 2. | 2022 |
| Mayo Clinic | $268,998 | Jacksonville, FL, US | Identify The Oncogenic Signaling Dependencies That Characterize Each Of The Cellular Subpopulations That Comprise A Glioblastoma Tumor, And From This Information Construct A Non-toxic Combination Of Kinase Inhibitors To Effectively Treat This Disease. Payment 1 Of 2. | 2022 |
| Notmykid | $1,000 | Scottsdale, AZ, US | Lifesaving Programs, Support, Resources, And Education To Empower Adn Educate Youth, Familes, And Communities With The Knowledge And Courage To Identify And Prevent Negative Youth Behavior. | 2022 |
| Neurotrials Llc | $450,000 | Phoenix, AZ, US | Cerebrospinal Fluid Analysis With T-gen. | 2022 |
| Neurotrials Llc | $5,470,000 | Phoenix, AZ, US | Prepayment Of 2023 Cerebrospinal Fluid Analysis. | 2022 |
| Neuro Trials Llc | $200,000 | Phoenix, AZ, US | Deposit For Ivy Brain Tumor Center Building Lobby. | 2022 |
| O'connor Institute | $500 | Phoenix, AZ, US | Advances Sandra Day O'connor's Distinguished Legacy And Lifetime Work To Advance Civics Education, Civic Engagement And Civil Discourse. | 2022 |
| Yale Cancer Center | $300,000 | New Haven, CT, US | Use Of A Novel Transformational Platform For Rapid Identification Of Targets And Treatments To Inhibit Growth And Invasion Of Glioblastoma Cells Based On Rapid Patient Sample Screening Using Novel Nano-engineering Techniques. Payment 2 Of 2. | 2022 |
| University Of Tx Md Anderson Cancer | $300,000 | Houston, TX, US | Project Seeks To Preclinically Optimize Novel Therapeutic Approaches For Atrx-deficient Malignant Gliomas Targeting G-quadruplex Dna Secondary Structure. Payment 1 Of 2. | 2022 |
| Barrow Neurological Fdn | $4,500 | Phoenix, AZ, US | Provides Philanthropic Support For Barrow Neurological Institute At St. Joseph's Hospital And Medical Center. Barrow Is An International Leader In The Treatment, Research, And Education Of Brain And Spinal Diseases, Conditions And Injuries. | 2022 |
| H Lee Moffitt Cancer Center | $300,000 | Rochester, MN, US | In Examining The Role Of Tumors Cells In Modulating Bone Marrow-derived Macrophages And Microglia, This Study Seeks To Tailor Novel Therapeutics For Targeting Of Tumor Associated Macrophages. Payment 2 Of 2. | 2022 |
| Virginia Tech | $250,000 | Roanoke, VA, US | To Inhibit Tumor Cell Invasion And Invasion, Targeted Therapeutics Will Be Coupled To Biomarker-based Imaging In Patient-specific Models Of Glioblastoma. Payment 2 Of 2. | 2022 |
| Vanderbilt University | $250,000 | Nashville, TN, US | Using Single-cell And Systems Biology Approaches In Glioblastoma, Cell Subtypes Will Be Mapped To Glioblastoma Tissues And Experimental Models, Enabling Identification And Preclinical Targeting Of Interactions Between Cancer Cells, Immune Cells, And Location Specific Resident Brain Cells. Payment 2 Of 2. | 2022 |
| Damon Runyon Cancer Research Fdn | $120,000 | New York, NY, US | Investigation Of A Biomarker Phase 2 Study To Evaluate Targeted Therapy Harboring Specific Genetic Alterations. Payment 3 | 2022 |
| Memorial Sloan Kettering Cancer Cen | $300,000 | New York, NY, US | Discover And Describe Dormant Tumor Cells Called Cancer Stem Cells That Reside Within Adult Glioma And Are Resistant To Current Therapies. Payment 1 Of 2. | 2022 |
| Columbia University Irving Medical | $250,000 | New York, NY, US | Targeting The Glioblastoma Master Regulator Cebp A Pharmacokinetics And Pharmacodynamics Surgical Study Of St101. Payment 1 Of 2. | 2022 |
| Mayo Clinic College Of Medicine | $300,000 | Rochester, MN, US | Evaluate Candidate Glioma Csf Proteomic Signatures To Help Understand And Monitor Glioma Evolution In Living Patients During Standard Of Care And Experimental Immunotherapy. Payment 1 Of 2. | 2022 |
| Amanda Hope Rainbow | $500 | Phoenix, AZ, US | Bringing Dignity And Comfort Into The Harsh World Of Childhood Cancer And Other Threatening Diseases. | 2022 |
| Lung Cancer Research Foundation | $150 | New York, NY, US | Improves Lung Cancer Outcomes By Funding Research For The Prevention, Diagnosis, Treatment And Cure Of Lung Cancer. | 2022 |
| Translational Genomics Research Tge | $78,293 | Phoenix, AZ, US | Neurological Sciences Internship Program At Tgen Designed To Give High School And Undergraduate Students Intensive, Hands-on Research Experience Working Alongside A Mentor-scientist To Learn About Translational Research While Investigating Questions Within Neurological Sciences. | 2022 |
| Ut Southwestern Medical Center | $210,430 | Dallas, TX, US | Preclinical Investigation Of Focus Ultrasound Guided Delivery To Facilitate A Lipoprotein-omega-3 Fatty Acid-based Biological Therapy In Glioblastoma. Payment 2 Of 2. | 2022 |
| Neuro Trials Llc | $5,000,000 | Phoenix, AZ, US | Ivy Brain Tumor Center Building Expansion Special Grant Amendment. | 2022 |
| Uc San Diego | $300,000 | La Jolla, CA, US | Small Molecule Regulation Of Rest Protein Levels Provides An Ideal Platform For Developing A New Therapeutic For The Treatment Of Glioblastoma Multiforme. Payment 1 Of 2. | 2022 |
| University Of Tx Md Anderson Cancer | $250,000 | Houston, TX, US | Develop Safe And Potent Drugs That Can Turn The Tumor Immune Microenvironment From Suppressive To Permissive, Thereby Helping The Immune System To Recognize And Kill Glioblastoma. Payment 1 Of 2. | 2022 |
| Swedish Medical Center | $300,000 | Seattle, WA, US | Assess Combinations Of Small Molecules And Immunotherapies For Killing Glioblastoma Tumor Cells In A Personalized Ex Vivo Ecosystem With Intact Tumor Microenvironment Using Multiplex Immunochemistry And Spatial Mapping Of Cell Types. Payment 1 Of 2. | 2022 |
| Mayo Clinic College Of Medicine | $208,347 | Rochester, MN, US | Immunostimulatory Bacterial Antigens Expressed In Oncolytic Viral Platforms Will Be Tested In Preclinical Models Of Glioblastoma To Overcome Immune Checkpoint Inhibitor Resistance. Payment 2 Of 2. | 2022 |
| Society Of St Vincent De Paul | $250,000 | Phoenix, AZ, US | Center For Family Wellness Established To Focus On The Prevention And Management Of Chronic Diseases Through Nutrition, Physical Activity And Overall Wellness. Its Culturally Grounded Bilingual Education Programs Encourage The Whole Family To Participate. Payment #3. | 2022 |
| Arcs Foundation | $8,800 | Artesia, CA, US | Advance Science And Technology In The United States By Providing Awards To Academically Outstanding Us Citizens Studying To Complete Degrees In Science, Engineering And Medical Research. | 2022 |
| University Of Michigan | $300,000 | Ann Arbor, MI, US | New Methods Will Be Developed To Measure The Activity Of Tumor Metabolic Pathways In Patients With Glioblastoma And To Determine Whether Drugs Designed To Block These Pathways Are Suitable. Payment 2 Of 2. | 2022 |
| Univ Of New Mexico Health Sciences | $300,000 | Albuquerque, NM, US | Identify Mechanisms Underlying Inflammatory Cell Contribution To The Emergence Of The Recurrent Tumor By Single-cell Analysis Of Residual Disease In Glioblastoma Patients. Payment 2 Of 2. | 2022 |
| Univ Of Miami Miller School Of Medi | $300,000 | Miami, FL, US | Using Patient Derived Orthotopic Xenograft Models And A Novel Immunocompetent Model Of Gbm, The Efficacy Of A Mtl-mmp Inhibitor In Combination With Radiation/tmz Will Be Tested To Determine Its Effects On The Immune Component Of The Tumor Microenvironment. Payment 2 Of 2. | 2022 |
| Mayo Clinic | $268,998 | Jacksonville, FL, US | Identify The Oncogenic Signaling Dependencies That Characterize Each Of The Cellular Subpopulations That Comprise A Glioblastoma Tumor, And From This Information Construct A Non-toxic Combination Of Kinase Inhibitors To Effectively Treat This Disease. Payment 1 Of 2. | 2022 |
| Notmykid | $1,000 | Scottsdale, AZ, US | Lifesaving Programs, Support, Resources, And Education To Empower Adn Educate Youth, Familes, And Communities With The Knowledge And Courage To Identify And Prevent Negative Youth Behavior. | 2022 |
| Neurotrials Llc | $450,000 | Phoenix, AZ, US | Cerebrospinal Fluid Analysis With T-gen. | 2022 |
| Neurotrials Llc | $5,470,000 | Phoenix, AZ, US | Prepayment Of 2023 Cerebrospinal Fluid Analysis. | 2022 |
| Neuro Trials Llc | $200,000 | Phoenix, AZ, US | Deposit For Ivy Brain Tumor Center Building Lobby. | 2022 |
| O'connor Institute | $500 | Phoenix, AZ, US | Advances Sandra Day O'connor's Distinguished Legacy And Lifetime Work To Advance Civics Education, Civic Engagement And Civil Discourse. | 2022 |
| Yale Cancer Center | $300,000 | New Haven, CT, US | Use Of A Novel Transformational Platform For Rapid Identification Of Targets And Treatments To Inhibit Growth And Invasion Of Glioblastoma Cells Based On Rapid Patient Sample Screening Using Novel Nano-engineering Techniques. Payment 2 Of 2. | 2022 |
| University Of Tx Md Anderson Cancer | $300,000 | Houston, TX, US | Project Seeks To Preclinically Optimize Novel Therapeutic Approaches For Atrx-deficient Malignant Gliomas Targeting G-quadruplex Dna Secondary Structure. Payment 1 Of 2. | 2022 |
| Barrow Neurological Fdn | $4,500 | Phoenix, AZ, US | Provides Philanthropic Support For Barrow Neurological Institute At St. Joseph's Hospital And Medical Center. Barrow Is An International Leader In The Treatment, Research, And Education Of Brain And Spinal Diseases, Conditions And Injuries. | 2022 |
| H Lee Moffitt Cancer Center | $300,000 | Rochester, MN, US | In Examining The Role Of Tumors Cells In Modulating Bone Marrow-derived Macrophages And Microglia, This Study Seeks To Tailor Novel Therapeutics For Targeting Of Tumor Associated Macrophages. Payment 2 Of 2. | 2022 |
| Virginia Tech | $250,000 | Roanoke, VA, US | To Inhibit Tumor Cell Invasion And Invasion, Targeted Therapeutics Will Be Coupled To Biomarker-based Imaging In Patient-specific Models Of Glioblastoma. Payment 2 Of 2. | 2022 |
| Vanderbilt University | $250,000 | Nashville, TN, US | Using Single-cell And Systems Biology Approaches In Glioblastoma, Cell Subtypes Will Be Mapped To Glioblastoma Tissues And Experimental Models, Enabling Identification And Preclinical Targeting Of Interactions Between Cancer Cells, Immune Cells, And Location Specific Resident Brain Cells. Payment 2 Of 2. | 2022 |
| Damon Runyon Cancer Research Fdn | $120,000 | New York, NY, US | Investigation Of A Biomarker Phase 2 Study To Evaluate Targeted Therapy Harboring Specific Genetic Alterations. Payment 3 | 2022 |
| Memorial Sloan Kettering Cancer Cen | $300,000 | New York, NY, US | Discover And Describe Dormant Tumor Cells Called Cancer Stem Cells That Reside Within Adult Glioma And Are Resistant To Current Therapies. Payment 1 Of 2. | 2022 |
| Columbia University Irving Medical | $250,000 | New York, NY, US | Targeting The Glioblastoma Master Regulator Cebp A Pharmacokinetics And Pharmacodynamics Surgical Study Of St101. Payment 1 Of 2. | 2022 |
| Mayo Clinic College Of Medicine | $300,000 | Rochester, MN, US | Evaluate Candidate Glioma Csf Proteomic Signatures To Help Understand And Monitor Glioma Evolution In Living Patients During Standard Of Care And Experimental Immunotherapy. Payment 1 Of 2. | 2022 |
| Amanda Hope Rainbow | $500 | Phoenix, AZ, US | Bringing Dignity And Comfort Into The Harsh World Of Childhood Cancer And Other Threatening Diseases. | 2022 |
| Lung Cancer Research Foundation | $150 | New York, NY, US | Improves Lung Cancer Outcomes By Funding Research For The Prevention, Diagnosis, Treatment And Cure Of Lung Cancer. | 2022 |
| Translational Genomics Research Tge | $93,395 | Phoenix, AZ, US | Neurological Sciences Internship Program At Tgen Designed To Give High School And Undergraduate Students Intensive, Hands-on Research Experience Working Alongside A Mentor-scientist To Learn About Translational Research While Investigating Questions Within Neurological Sciences. | 2021 |
| Ut Southwestern Medical Center | $210,430 | Dallas, TX, US | Preclinical Investigation Of Focus Ultrasound Guided Delivery To Facilitate A Lipoprotein-omega-3 Fatty Acid-based Biological Therapy In Glioblastoma. Payment 1 Of 2. | 2021 |
| Neuro Trials Llc | $5,000,000 | Phoenix, AZ, US | Ivy Brain Tumor Center Building Expansion. Payment 2. | 2021 |
| Az Corona Virus Relief Fund | $1,000,000 | Phoenix, AZ, US | Direct Costs For 24/7 Vaccination Pod Efforts In The State Of Arizona. | 2021 |
| University Of Tx Md Anderson Cancer | $-268,349 | Houston, TX, US | Return Of Unused Funds. | 2021 |
| Swedish Medical Center | $-313,178 | Seattle, WA, US | Return Of Unused Funds. | 2021 |
| Mayo Clinic College Of Medicine | $300,000 | Rochester, MN, US | Immunostimulatory Bacterial Antigens Expressed In Oncolytic Viral Platforms Will Be Tested In Preclinical Models Of Glioblastoma To Overcome Immune Checkpoint Inhibitor Resistance. Payment 1 Of 2. | 2021 |
| Emory University | $250,000 | Atlanta, GA, US | (year 2 Of 2)dr Renee Read Emerging Leader Award - Using Pre-clinical Experimental Models, Glioblastomas Tumors Display Therapeutic Vulnerability To Pharmacologic Treatment With The Yap/taz Inhibitor And Porphyrin Derivative Verteporfin. Testing Of An Fda-approved Liposomal Formulation Of Verteporfin In A Phase 1/2 Clinical Trials In Human Glioblastoma Patients And To Identify Biomarkers Predictive Of Therapeutic Response To This Drug. | 2021 |
| Society Of St Vincent De Paul | $250,000 | Phoenix, AZ, US | Center For Family Wellness Established To Focus On The Prevention And Management Of Chronic Diseases Through Nutrition, Physical Activity And Overall Wellness. Its Culturally Grounded Bilingual Education Programs Encourage The Whole Family To Participate. Payment #2. | 2021 |
| Fred Hutchison Cancer Research Cent | $300,000 | Seattle, WA, US | (year 2 Of 2) Dr Eric Holland Translational Glioma Award - Co Clinical Trials For Gene Fusion Driven Brain Tumors Using Mouse Models To Inform Drug Development. | 2021 |
| Arcs Foundation | $8,800 | Artesia, CA, US | Advance Science And Technology In The United States By Providing Awards To Academically Outstanding Us Citizens Studying To Complete Degrees In Science, Engineering And Medical Research. | 2021 |
| University Of Michigan | $300,000 | Ann Arbor, MI, US | New Methods Will Be Developed To Measure The Activity Of Tumor Metabolic Pathways In Patients With Glioblastoma And To Determine Whether Drugs Designed To Block These Pathways Are Suitable. Payment 1 Of 2. | 2021 |
| Univ Of New Mexico Health Sciences | $300,000 | Albuquerque, NM, US | Identify Mechanisms Underlying Inflammatory Cell Contribution To The Emergence Of The Recurrent Tumor By Single-cell Analysis Of Residual Disease In Glioblastoma Patients. Payment 1 Of 2. | 2021 |
| Regents Of Univ Of Ca Ucla | $-31,677 | Los Angeles, CA, US | Refund Of Unused Funds. | 2021 |
| Univ Of Miami Miller School Of Medi | $300,000 | Miami, FL, US | Using Patient Derived Orthotopic Xenograft Models And A Novel Immunocompetent Model Of Gbm, The Efficacy Of A Mtl-mmp Inhibitor In Combination With Radiation/tmz Will Be Tested To Determine Its Effects On The Immune Component Of The Tumor Microenvironment. Payment 1 Of 2. | 2021 |
| City Of Hope Medical Center | $300,000 | Duarte, CA, US | Enhancing Chimeric Antigen Receptor (car) T Cell Therapy For Glioblastoma Through The Induction Of Ifn-signaling Pathways. This Approach Aims To Address Two Of The Major Challenges Of Immunotherapies For Gbm, The Immunosuppressive Tumor Microenvironment (tme) And The Tumor Heterogeneity. Payment 2 Of 2. | 2021 |
| Mayo Clinic | $300,000 | Jacksonville, FL, US | Development Of A Transcriptomically-guided Therapeutic Strategy That Combines Targeted Therapies That Both Effectively Treat Glioblastoma And Prevent The Emergence Of Treatment Resistance. Payment 2 Of 2. | 2021 |
| Notmykid | $575 | Scottsdale, AZ, US | Lifesaving Programs, Support, Resources, And Education To Empower Adn Educate Youth, Familes, And Communities With The Knowledge And Courage To Identify And Prevent Negative Youth Behavior. | 2021 |
| Maricopa Community Colleges Foundat | $1,000 | Tempe, AZ, US | The Foundation Actively Seeks Contributions From A Variety Of Private Sources Including Individuals, Corporations, And Foundations And Believes That Everyone Has The Opportunity To Improve Their Lives Through Education. Mcccdf Works To Fulfill This Vision With Its Mission To Boldly Impact The Community Through Innovative And Strategic Partnerships For The Growth And Benefit Of The Maricopa Community Colleges, Its Students, Faculty, And Staff. | 2021 |
| Dana-farber Cancer Institute | $-610,671 | Boston, MA, US | Return Of Unused Funds. | 2021 |
| Neurotrials Llc | $5,152,500 | Phoenix, AZ, US | Ivy Brain Tumor Center. Payments 4 & 5. | 2021 |
| Neurotrials Llc | $494,429 | Phoenix, AZ, US | Advertising #3. Advertising At Sky Harbor Airport. | 2021 |
| Neuro Trials Llc | $600,000 | Phoenix, AZ, US | Restricted Funds For The Purchase Of A Liquid Chromatography-tandem Mass Spectrometry (lc-ms/ms) | 2021 |
| Neurotrials Llc | $25,000 | Phoenix, AZ, US | Ivy Brain Tumor Center - Unrestricted | 2021 |
| Yale Cancer Center | $300,000 | New Haven, CT, US | Use Of A Novel Transformational Platform For Rapid Identification Of Targets And Treatments To Inhibit Growth And Invasion Of Glioblastoma Cells Based On Rapid Patient Sample Screening Using Novel Nano-engineering Techniques. Payment 1 Of 2. | 2021 |
| H Lee Moffitt Cancer Center | $300,000 | Rochester, MN, US | In Examining The Role Of Tumors Cells In Modulating Bone Marrow-derived Macrophages And Microglia, This Study Seeks To Tailor Novel Therapeutics For Targeting Of Tumor Associated Macrophages. Payment 1 Of 2. | 2021 |
| Virginia Tech | $250,000 | Roanoke, VA, US | To Inhibit Tumor Cell Invasion And Invasion, Targeted Therapeutics Will Be Coupled To Biomarker-based Imaging In Patient-specific Models Of Glioblastoma. Payment 1 Of 2. | 2021 |
| Vanderbilt University | $250,000 | Nashville, TN, US | Using Single-cell And Systems Biology Approaches In Glioblastoma, Cell Subtypes Will Be Mapped To Glioblastoma Tissues And Experimental Models, Enabling Identification And Preclinical Targeting Of Interactions Between Cancer Cells, Immune Cells, And Location Specific Resident Brain Cells. Payment 1 Of 2. | 2021 |
| Damon Runyon Cancer Research Fdn | $110,000 | New York, NY, US | Investigation Of A Biomarker Phase 2 Study To Evaluate Targeted Therapy Harboring Specific Genetic Alterations. Payment 2 Of 2 | 2021 |
| Translational Genomics Research Tge | $92,683 | Phoenix, AZ, US | Neurological Sciences Internship Program At Tgen Designed To Give High School And Undergraduate Students Intensive, Hands-on Research Experience Working Alongside A Mentor-scientist To Learn About Translational Research While Investigating Questions Within Neurological Sciences. | 2020 |
| Estelize Masales | $25,000 | Phoenix, AZ, US | Clinical Trial Expenses For Fund Chopper | 2020 |
| Neuro Trials Llc | $5,000,000 | Phoenix, AZ, US | Building Expansion. | 2020 |
| Az Corona Virus Relief Fund | $5,000,000 | Phoenix, AZ, US | Direct Costs For Personal Protection Equipment And Masks For Arizona Hospitals. | 2020 |
| University Of Tx Md Anderson Cancer | $300,000 | Houston, TX, US | (year 1 Of 2) Amy Heimberger Md - The Use Of Stat 3 Inhibition In Combination With Radiation To Induce Antigen Presenting Cell-t Cell Immunological Synapses And Subsequent T Cell Activation In The Glioma Microenvironment. | 2020 |
| Swedish Medical Center | $-986,048 | Seattle, WA, US | Return Of Unused Funds. | 2020 |
| Mayo Clinic Jacksonville | $300,000 | Jacksonville, FL, US | (year 1 Of 2) Dr Rosenfeld - Development Of A Transcriptomically-guided Therapeutic Strategy That Combines Targeted Therapies That Both Effectively Treat Glioblastoma And Prevent The Emergence Of Treatment Resistance. | 2020 |
| Emory University | $250,000 | Atlanta, GA, US | (year 1 Of 2)dr Renee Read Emerging Leader Award - Using Pre-clinical Experimental Models To Identify Biomarkers Predictive Of Therapeutic Response To An Fda-approved Liposomal Formulation Of Verteporfin. | 2020 |
| Society Of St Vincent De Paul | $250,000 | Phoenix, AZ, US | Center For Family Wellness Established To Focus On The Prevention And Management Of Chronic Diseases Through Nutrition, Physical Activity And Overall Wellness. Its Culturally Grounded Bilingual Education Programs Encourage The Whole Family To Participate. | 2020 |
| Fred Hutchison Cancer Research Cent | $300,000 | Seattle, WA, US | (year 1 Of 2) Dr Eric Holland Translational Glioma Award - Co Clinical Trials For Gene Fusion Driven Brain Tumors Using Mouse Models To Inform Drug Development. | 2020 |
| Translational Genomics Research Tge | $500,000 | Phoenix, AZ, US | Serologic (antibody) Testing To Determine Whether Antibodies Specific To A Pathogen Of Interest Are Present In A Blood Sample. (a Positive Serology Test Result Indicates Past Infection Or Vaccination Status.) Using The Inbios Scov-2 Detect Elisa Diagnostic Test For The Qualitative Detection Of Human Antibodies In Serum Specimens From Indivduals Suspected Of Prior Infection With Or Vaccination Against Sars-cov-2 Virus. | 2020 |
| City Of Hope Medical Center | $300,000 | Duarte, CA, US | Renee Power(emerging Leader Award) Advancing Il13ra2-car T Therapy. | 2020 |
| Arizona Women's Board | $100 | Paradise Valley, AZ, US | Prevention Of Kidney Disease Through Awareness, Education And Research. | 2020 |
| Neurotrials Llc | $2,995,000 | Phoenix, AZ, US | Establish A Phoenix-based Center For Glioblastoma Drug Discovery (the Ivy Brain Tumor Research Center) Emphasizing Industry -partnered Drug Development Paired With A Large Portfolio Of Phase 0/ii Trials And Randomized Phase Ii Trials. | 2020 |
| Amanda Hope Rainbow Angels | $1,000 | Phoenix, AZ, US | Bring Dignity And Hope Into The Harsh World Of Childhood Cancer And Other Life-threatening Diseases. | 2020 |
| Damon Runyon Cancer Research Fdn | $100,000 | New York, NY, US | Investigation Of A Biomarker Phase 2 Study To Evaluate Targeted Therapy Harboring Specific Genetic Alterations. | 2020 |
Foundations Similar to Ben And Catherine Ivy Foundation
Discover 5 foundations with comparable assets ($113,170,078-$342,478,446), similar grant patterns, and geographic focus in AZ that may also align with your organization's funding needs and grant seeking strategy.
| Foundation Name | Total Assets | Typical Grant Size | Service Area | Similarity Match |
|---|---|---|---|---|
|
The Hickey Family Foundation
EIN: 86-6331657 | 230 grants awarded |
$150,742,199
(↓ Smaller) |
$172,700
median grant |
Mesa, AZ
Same state |
|
|
Greentree Foundation
EIN: 13-3132117 | 25 grants awarded |
$334,765,569
(≈ Similar) |
$200,000
median grant |
Manhasset, NY |
|
|
Bluecross Blueshield Of South Carolina
EIN: 22-3847938 | 327 grants awarded |
$328,060,513
(≈ Similar) |
$154,703
median grant |
Columbia, SC |
|
|
Skylight Charitable Trust
EIN: 85-6456699 | 68 grants awarded |
$113,170,078
(↓ Smaller) |
$145,000
median grant |
Scottsdale, AZ
Same state |
|
|
Rise8 Foundation
EIN: 26-6476207 | 107 grants awarded |
$342,478,446
(≈ Similar) |
$200,000
median grant |
Hunt Valley, MD |
|
Related Foundation Resources in AZ:
Contact Information
Official contact details for Ben And Catherine Ivy Foundation as registered with the IRS. These details are essential for grant applications, correspondence, and due diligence processes.
| EIN | 27-3322123 |
| Website | http://www.ivyfoundation.org |
| Address | 6710 N SCOTTSDALE RD STE 235 Scottsdale, AZ 85253-4407 |
Key People (3)
Board members, trustees, and key staff who oversee Ben And Catherine Ivy Foundation's grant making decisions and strategic direction. Understanding leadership composition can provide insights into foundation priorities and potential networking opportunities.
| President | Catherine E Ivy |
|---|---|
| Treasurer | Megan Edwards |
| Secretary | Stephanie Mcrae Esq |
Forms 990-PF
IRS Form 990-PF filings provide comprehensive financial information, grant details, and operational data. These documents are essential resources for understanding foundation capacity, giving patterns, and strategic priorities.
Form 990-PF Research Tips
- Review Part XV for detailed grant recipient information and funding purposes
- Check Part I for total assets, annual giving amounts, and payout requirements
- Examine Part VIII for key personnel compensation and board structure
- Look for trends across multiple years to understand giving patterns
About This Foundation Profile
This comprehensive foundation profile for Ben And Catherine Ivy Foundation is powered by Grant Bay's advanced foundation research platform. Our system analyzes IRS Form 990-PF filings, grant histories, and philanthropic patterns to provide nonprofit organizations with actionable intelligence for grant seeking success.
Data Sources & Accuracy
All information is derived from official IRS filings and public records. Grant Bay processes thousands of Form 990-PF documents to extract grant details, financial data, and organizational information. Data accuracy depends on foundation reporting quality and IRS filing completeness.
Research Applications
Use this profile for prospect research, grant strategy development, application preparation, and relationship building. Combine this data with additional research on foundation priorities, application processes, and board member backgrounds for comprehensive grant seeking strategies.
Data Currency: Last updated
February 2026
based on IRS Form 990-PF filings. Foundation information reflects most recent available tax year data.